Pharmaceuticals & Therapeutics

What We Offer

As one of the oldest Health and Life Sciences practices in our industry, we have a track record of strategic launch support and lifecycle management for many of the industry’s leading therapies, including drug technologies that have revolutionized healthcare. Our experience in commercialization, forecasting, positioning, pricing, and lifecycle management spans virtually every therapeutic category and nearly every drug class, as well as implantable devices, instruments, and diagnostic technologies. Our role in helping bring novel compounds and platform technologies to market has allowed us to guide some of the world’s most innovative small enterprises through their transformation to leading global players reshaping standards of medical care. 

  • Expertise in a broad range of disease categories — including significant experience in orphan drugs and paradigm-changing therapeutics
  • In-depth knowledge of the regulatory environment and 21st century challenges of drug commercialization
  • Keen insight on clinical practice in an increasingly managed, outcomes-driven environment
  • Deep understanding of changing health delivery structures and their impact on clinical decisions
  • Documented leadership in the field, with continuing commitment to self-funded research and a history of contributions to peer-reviewed clinical journals

Guidance All Along the Commercial Pathway 

Our Resources and Capabilities

  • Comprehensive and inventive portfolio of techniques, all continually updated to support an industry confronting challenge and change
  • Resident Qualitative specialists and an in-house Analytics team ensuring integrative perspective on marketing problems and research solutions
  • Impeccable research design and rigorous execution needed to guide public policy research, including REMS assignments
  • Pharmaco-economic modeling, health outcomes, and database analysis, including analytic proficiency with secondary data sets that supports a coherent, clinically astute interpretation
  • Ready access to some of the world’s leading KOLs as well as staff at Payer organizations who set reimbursement policy
  • Specialized expertise in DTC ROI and patient-driven revenue models
  • A comprehensive suite of choice and driver models to guide trials design, pricing and forecasting
  • Industry-leading expertise in actionable segmentation modeling
  • Specialized support for innovation and commercialization strategy through our NAscence practice

Therapeutic Expertise

  • Cardiovascular Medicine
  • Oncology/Hematology
  • Immunology
  • Endocrinology
  • Virology
  • Pulmonology
  • Musculoskeletal Disease
  • Gastroenterology
  • Dermatology
  • Neurology
  • Orphan Drugs
  • Respiratory Disease
  • Psychiatric Disease
  • GI Disease
  • Metabolic Disease
  • Neurology & Pain
  • Infectious Disease

Our 360-Degree View of Industry Stakeholders

Extensive consumer marketing experience, combined with brand strategy work on behalf of health insurers, gives us a broad perspective on stakeholder interactions, and informs our thinking about how all customers will define “value” in an evidence-based, “Affordable Care” environment. 

We also provide service to insurers and hospitals seeking to understand their markets, bolster brand strength, and sustain customer commitment.